Related Experiment Video
Updated: May 30, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
CA-SQBG: Cross-attention guided Siamese quantum BiGRU for drug-drug interaction extraction
Ting Zhang1, Changqing Yu1, Shanwen Zhang1
1College of Electronic Information, Xijing University, Xi'an, China.
Abstract:
Accurate and efficient drug-drug interaction extraction (DDIE) from the medical corpus is essential for pharmacovigilance, drug therapy and drug development. To solve the problems of unbalance dataset and lack of accurate manual annotations in DDIE, a cross-attention guided Siamese quantum BiGRU (CA-SQBG) is constructed to improve feature representation learning ability for DDIE. It mainly consists of two quantum BiGRUs (QBiGRUs) and a cross-attention, where two QBiGRUs are Siamese implemented in a variational quantum environment to learn the contextual semantic feature representation of drug pairs, cross-attention is employed to learn mutual information from the Siamese QBiGRUs, which in turn allows the two modules to extract DDI more collaboratively. Unlike BiGRU, Siamese QBiGRUs uses internal and external dependencies in quaternion algebra to map DDI correlations within and between multidimensional features, whereas BiGRU can only capture dependencies within sequences. CA-SQBG is evaluated on the DDIExtraction2013 dataset, and the results demonstrate that it can effectively capture the inter- and intra-dependencies within multimodal features with few parameters, using a small number of training samples, and is superior to the most advanced DDIE methods. CA-SQBG offers potential applications for quantum computing and Siamese networks in the field of DDIE. Code is available on https://github.com/xaycq/CA-SQBG.
More Related Videos
Related Concept Videos
Quantitative Aspects of Drug-Receptor Interaction
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

